NDC properties for "Purixan 20 MG per 1 ML Oral Suspension" (RxCUI 1536490)
About this data
The tables show NDC propoerties for Purixan 20 MG per 1 ML Oral Suspension with the RxCUI 1536490
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Purixan 20 MG per 1 ML Oral Suspension (RxCUI 1536490)
| MMSL_CODE | BD14208 |
|---|---|
| NDA | NDA205919 |
| RxCUI | 1536490 |
| SPL_SET_ID | 9fd27952-7787-47d9-b6cf-7af2dc38217b |
| Prescribable Synonym | Purixan 2000 MG in 100 mL Oral Suspension |
| RXNAV_STR | Purixan 20 MG/ML Oral Suspension |
| RxNorm Name | mercaptopurine 20 MG/ML Oral Suspension [Purixan] |
| RxNorm Synonym | Purixan 20 MG per 1 ML Oral Suspension |
| RxNorm Synonym | Purixan 20 MG/ML Oral Suspension |
| RxNorm Synonym | Purixan 2000 MG per 100 ML Oral Suspension |
| Related queries | Interactions (for RxCUI 1536490) |
NDC Properties
NDC Item 62484002001
| NDC 9 | 62484-0020 |
|---|---|
| NDC 10 | 62484-0020-1 |
| NDC Item | 62484002001 |
| Packaging | 100 mL in 1 BOTTLE |
| FDA SPL set id | 823076 |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-04-28 |
| Marketing status | ACTIVE |
| NDA | NDA205919 |
| Related queries | Properties for NDC 9 62484-0020 |
NDC Item 62484002002
| NDC 9 | 62484-0020 |
|---|---|
| NDC 10 | 62484-0020-2 |
| NDC Item | 62484002002 |
| Packaging | 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1) |
| FDA SPL set id | 823076 |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-04-28 |
| Marketing status | ACTIVE |
| NDA | NDA205919 |
| Related queries | Properties for NDC 9 62484-0020 |
NDC Item 62484002001
| NDC 9 | 62484-0020 |
|---|---|
| NDC 10 | 62484-0020-1 |
| NDC Item | 62484002001 |
| Packaging | 100 mL in 1 BOTTLE |
| FDA SPL set id | 823076 |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-04-28 |
| Marketing status | ACTIVE |
| NDA | NDA205919 |
| Related queries | Properties for NDC 9 62484-0020 |
NDC Item 62484002002
| NDC 9 | 62484-0020 |
|---|---|
| NDC 10 | 62484-0020-2 |
| NDC Item | 62484002002 |
| Packaging | 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1) |
| FDA SPL set id | 823076 |
| Labeler | Nova Laboratories, Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2014-04-28 |
| Marketing status | ACTIVE |
| NDA | NDA205919 |
| Related queries | Properties for NDC 9 62484-0020 |